Navigation Links
One More Drug to Fight Brain Cancer

The Eli Lilly and Company, a leading pharmaceutical manufacturer, has announced that the European Medicines Agency (EMEA) has granted enzastaurin,// an anti-cancer drug the status of an orphan drug.

(Orphan drug status gives the drug's manufacturer a seven-year right to exclusively market the compound. This protection of unpatentable orphan drugs encourages their development by greatly increasing their profitability.)

Enzastaurin, being developed by the Eli Lilly, is described as an investigational and multi-targeted oral cancer agent. It is particularly useful in a type of cancer called, non-Hodgkin's lymphoma. This type of cancer affects such regions as brain, bone-marrow and stomach.

Enrolment into a phase III clinical trial of enzastaurin is underway. Specifically, enzastaurin is being investigated as a maintenance therapy to prevent disease relapse.

Earlier the Lilly executives had said that the new drug could be useful in the treatment of recurring glioblastoma, a type of brain cancer.

Glioblastoma is part of the larger group of tumors that impact the central nervous system, known as gliomas. Patients with highly recurrent glioblastoma are usually at a more advanced stage of the disease. They may face altered brain function or death due to the tumor's rapid growth rate. At the moment there are very few adequate treatments for this disease.

Enzastaurin is the first targeted agent of Lilly Oncology to enter into late stage clinical development.It heralds a new phase of innovation for the group,it is stated.


Page: 1

Related medicine news :

1. Fight Heart disease and Pain with Meditation
2. Fight anemia by fortifying crops with iron!!!!!!!!
3. Fight arthritic pain with acupuncture
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Fight against E.coli
6. Red Wine Helps Fight Heart disease
7. Fish Oil Fights Arrhythmias, Sudden Death
8. SARS-Free Taiwan to Mark End Phase of Global Fight
9. Few Parents Help Kids Fight Acne
10. Common Cold Found to Fight Cancer
11. The Possibility Of Fighting HIV with Another Virus Questioned
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... 2015 , ... Many people know of the common symptoms of low thyroid ... skin. But many people who find their cholesterol levels and weight are creeping up ... especially if they don’t have any of the other symptoms. , Thyroid hormone plays ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for Tuberous Sclerosis Complex (TSC), as well as raising public awareness of the ... they need it—presented a third donation of $35,000 to bolster progress at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
(Date:11/25/2015)... ... November 25, 2015 , ... Students and parents have something to ... of the Create Real Impact awards. California Casualty is proud to support ... tide of distracted and reckless driving, the number one killer of young drivers. ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... November 25, 2015 Developmental, commercial, ... boosting the profitability of pharmaceutical products, says GBI ... and regulatory/legal strategies all play a key role ... GBI Research . --> Developmental, ... key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology: